Compare · PARK vs PGNY
PARK vs PGNY
Side-by-side comparison of Park Dental Partners Inc. (PARK) and Progyny Inc. (PGNY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PARK and PGNY operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- PGNY is the larger of the two at $1.98B, about 20.4x PARK ($97.3M).
- Over the past year, PARK is up 98.8% and PGNY is up 14.2% - PARK leads by 84.6 points.
- Both names hit the wire about 6 times in the past 4 weeks.
- PGNY has more recent analyst coverage (25 ratings vs 2 for PARK).
- Company
- Park Dental Partners Inc.
- Progyny Inc.
- Price
- -
- -
- Market cap
- $97.3M
- $1.98B
- 1M return
- +11.90%
- -18.21%
- 1Y return
- +98.76%
- +14.16%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2019
- News (4w)
- 6
- 6
- Recent ratings
- 2
- 25
Progyny Inc.
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Latest PARK
- Officer Law Alan Siems gifted 80 shares, decreasing direct ownership by 0.04% to 180,961 units (SEC Form 4)
- SEC Form 10-Q filed by Park Dental Partners Inc.
- Park Dental Partners Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Park Dental Partners Announces Second Quarter 2026 Results
- Park Dental Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
- Park Dental Partners, Inc. Announces Agreement to Acquire Village Family Dental Services Organization - Enters North Carolina Market
- Park Dental Partners Announces Dates for Second Quarter 2026 Earnings Release and Conference Call
- SEC Form 4 filed by Director Smith Philip Irving
- SEC Form 4 filed by CEO and Chairman Swenson Peter G
- SEC Form 4 filed by Officer Steele Christopher Eugene
Latest PGNY
- Wells Fargo initiated coverage on Progyny with a new price target
- Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference
- SEC Form 10-Q filed by Progyny Inc.
- Progyny Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Progyny, Inc. Announces Second Quarter 2026 Results
- Amendment: SEC Form SCHEDULE 13G/A filed by Progyny Inc.
- Progyny downgraded by Barclays with a new price target
- Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report
- Chief Operating Officer Cummings Melissa B covered exercise/tax liability with 1,193 shares and sold $70,910 worth of shares (2,244 units at $31.60) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 69,934 units (SEC Form 4) to satisfy withholding obligation
- Chief Product Officer Clapp Geoffrey covered exercise/tax liability with 819 shares, decreasing direct ownership by 1% to 59,828 units (SEC Form 4) to satisfy withholding obligation